James Paul Scopa Dice Therapeutics, Inc. (DICE) insider trading activity

DICE Quotes by TradingView

James Paul Scopa is Director of DICE Therapeutics, Inc.. Currently has a direct ownership of 0 shares of DICE, which is worth approximately $0. The most recent transaction as insider was on Aug 09, 2023, when has been sold 15,199 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

James Paul Scopa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2023
SELL
Sale (or disposition) back to the issuer
-
15,199 Reduced 100.0%
0 Common Stock
May 01 2023
SELL
Bona fide gift
-
6,923 Reduced 31.29%
15,199 Common Stock
Oct 24 2022
SELL
Bona fide gift
-
30,719 Reduced 58.13%
22,122 Common Stock
Sep 15 2021
BUY
Open market or private purchase
$102,000 $17.0 p/Share
6,000 Added 9.7%
55,841 Common Stock

Also insider at

ALGS
Aligos Therapeutics, Inc. Healthcare
ADVM
Adverum Biotechnologies, Inc. Healthcare
JPS

James Paul Scopa

Director
South San Francisco, CA

Track Institutional and Insider Activities on DICE

Follow DICE Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DICE shares.

Notify only if

Insider Trading

Get notified when an Dice Therapeutics, Inc. insider buys or sells DICE shares.

Notify only if

News

Receive news related to DICE Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DICE